Fluorine in PDB 5dg5: Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Enzymatic activity of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
All present enzymatic activity of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157:
2.7.10.1;
Protein crystallography data
The structure of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157, PDB code: 5dg5
was solved by
B.D.Smith,
M.D.Kaufman,
C.B.Leary,
B.A.Turner,
S.A.Wise,
Y.M.Ahn,
R.J.Booth,
T.M.Caldwell,
C.L.Ensinger,
M.M.Hood,
W.-P.Lu,
T.W.Patt,
W.C.Patt,
T.J.Rutkoski,
T.Samarakoon,
H.Telikepalli,
L.Vogeti,
S.Vogeti,
K.M.Yates,
L.Chun,
L.J.Stewart,
M.Clare,
D.L.Flynn,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.65 /
2.60
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
37.130,
115.880,
90.160,
90.00,
92.92,
90.00
|
R / Rfree (%)
|
20.4 /
24.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
(pdb code 5dg5). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157, PDB code: 5dg5:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 1 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1401
b:37.6
occ:1.00
|
F37
|
A:5B41401
|
0.0
|
37.6
|
1.0
|
C34
|
A:5B41401
|
1.4
|
36.6
|
1.0
|
C35
|
A:5B41401
|
2.4
|
36.9
|
1.0
|
C33
|
A:5B41401
|
2.4
|
34.8
|
1.0
|
CD1
|
A:LEU1195
|
3.4
|
35.8
|
1.0
|
CG1
|
A:VAL1139
|
3.5
|
27.9
|
1.0
|
CD2
|
A:LEU1195
|
3.6
|
34.7
|
1.0
|
C36
|
A:5B41401
|
3.6
|
37.1
|
1.0
|
C32
|
A:5B41401
|
3.6
|
34.9
|
1.0
|
CE2
|
A:PHE1134
|
3.8
|
35.2
|
1.0
|
CD2
|
A:PHE1134
|
3.9
|
35.4
|
1.0
|
CG
|
A:LEU1195
|
4.1
|
34.2
|
1.0
|
C31
|
A:5B41401
|
4.1
|
35.2
|
1.0
|
O
|
A:VAL1220
|
4.3
|
25.3
|
1.0
|
CE2
|
A:PHE1200
|
4.4
|
37.6
|
1.0
|
CB
|
A:VAL1139
|
4.6
|
28.0
|
1.0
|
CG1
|
A:VAL1220
|
4.6
|
27.1
|
1.0
|
CG2
|
A:VAL1139
|
4.7
|
29.2
|
1.0
|
C
|
A:VAL1220
|
4.7
|
26.6
|
1.0
|
CD2
|
A:HIS1202
|
4.8
|
44.1
|
1.0
|
CD2
|
A:PHE1200
|
4.8
|
37.7
|
1.0
|
CZ
|
A:PHE1200
|
4.9
|
38.0
|
1.0
|
CZ
|
A:PHE1134
|
4.9
|
34.6
|
1.0
|
CA
|
A:ALA1221
|
4.9
|
29.2
|
1.0
|
CG
|
A:PHE1134
|
5.0
|
36.5
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 2 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1401
b:33.1
occ:1.00
|
F7
|
A:5B41401
|
0.0
|
33.1
|
1.0
|
C1
|
A:5B41401
|
1.3
|
31.5
|
1.0
|
C2
|
A:5B41401
|
2.3
|
31.9
|
1.0
|
C6
|
A:5B41401
|
2.4
|
32.0
|
1.0
|
O9
|
A:5B41401
|
2.7
|
32.4
|
1.0
|
CG1
|
A:VAL1092
|
3.3
|
33.8
|
1.0
|
CG2
|
A:VAL1092
|
3.6
|
35.7
|
1.0
|
C3
|
A:5B41401
|
3.6
|
31.7
|
1.0
|
C5
|
A:5B41401
|
3.6
|
31.2
|
1.0
|
CB
|
A:LYS1110
|
3.7
|
32.5
|
1.0
|
CD1
|
A:LEU1157
|
3.7
|
33.3
|
1.0
|
CE1
|
A:PHE1223
|
3.9
|
34.4
|
1.0
|
C10
|
A:5B41401
|
3.9
|
32.9
|
1.0
|
CD
|
A:LYS1110
|
4.0
|
36.5
|
1.0
|
CB
|
A:VAL1092
|
4.0
|
34.8
|
1.0
|
C4
|
A:5B41401
|
4.1
|
31.2
|
1.0
|
CG
|
A:LYS1110
|
4.2
|
35.0
|
1.0
|
CD1
|
A:PHE1223
|
4.3
|
34.0
|
1.0
|
C15
|
A:5B41401
|
4.5
|
31.9
|
1.0
|
O24
|
A:5B41401
|
4.5
|
32.7
|
1.0
|
CA
|
A:LYS1110
|
4.6
|
30.6
|
1.0
|
N22
|
A:5B41401
|
4.8
|
31.6
|
1.0
|
CZ
|
A:PHE1223
|
4.9
|
35.7
|
1.0
|
N
|
A:LYS1110
|
4.9
|
28.2
|
1.0
|
CB
|
A:ALA1108
|
4.9
|
30.9
|
1.0
|
C11
|
A:5B41401
|
4.9
|
32.7
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 3 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1401
b:32.9
occ:1.00
|
F8
|
A:5B41401
|
0.0
|
32.9
|
1.0
|
C4
|
A:5B41401
|
1.3
|
31.2
|
1.0
|
C3
|
A:5B41401
|
2.4
|
31.7
|
1.0
|
C5
|
A:5B41401
|
2.4
|
31.2
|
1.0
|
N22
|
A:5B41401
|
2.7
|
31.6
|
1.0
|
CD2
|
A:LEU1140
|
3.1
|
28.9
|
1.0
|
CB
|
A:ALA1221
|
3.2
|
29.9
|
1.0
|
O27
|
A:5B41401
|
3.5
|
37.5
|
1.0
|
C2
|
A:5B41401
|
3.6
|
31.9
|
1.0
|
C6
|
A:5B41401
|
3.7
|
32.0
|
1.0
|
CB
|
A:PHE1223
|
3.7
|
33.4
|
1.0
|
CA
|
A:PHE1223
|
3.8
|
33.3
|
1.0
|
N
|
A:PHE1223
|
3.9
|
35.2
|
1.0
|
C23
|
A:5B41401
|
4.1
|
32.2
|
1.0
|
CG
|
A:PHE1223
|
4.1
|
33.5
|
1.0
|
C1
|
A:5B41401
|
4.1
|
31.5
|
1.0
|
CD1
|
A:PHE1223
|
4.3
|
34.0
|
1.0
|
CG
|
A:MET1211
|
4.3
|
36.4
|
1.0
|
N
|
A:ASP1222
|
4.3
|
34.1
|
1.0
|
CA
|
A:ALA1221
|
4.4
|
29.2
|
1.0
|
SD
|
A:MET1211
|
4.5
|
40.3
|
1.0
|
C
|
A:ASP1222
|
4.5
|
36.6
|
1.0
|
C26
|
A:5B41401
|
4.5
|
34.4
|
1.0
|
CG
|
A:LEU1140
|
4.5
|
29.1
|
1.0
|
C
|
A:ALA1221
|
4.8
|
31.4
|
1.0
|
O9
|
A:5B41401
|
4.8
|
32.4
|
1.0
|
C25
|
A:5B41401
|
4.9
|
33.8
|
1.0
|
O24
|
A:5B41401
|
4.9
|
32.7
|
1.0
|
CD2
|
A:PHE1223
|
4.9
|
34.5
|
1.0
|
CB
|
A:LEU1140
|
4.9
|
28.8
|
1.0
|
CD1
|
A:LEU1157
|
5.0
|
33.3
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 4 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1401
b:40.2
occ:1.00
|
F37
|
B:5B41401
|
0.0
|
40.2
|
1.0
|
C34
|
B:5B41401
|
1.3
|
35.6
|
1.0
|
C33
|
B:5B41401
|
2.4
|
33.5
|
1.0
|
C35
|
B:5B41401
|
2.4
|
36.5
|
1.0
|
CD1
|
B:LEU1195
|
3.4
|
30.9
|
1.0
|
CG1
|
B:VAL1139
|
3.4
|
25.9
|
1.0
|
C32
|
B:5B41401
|
3.6
|
34.7
|
1.0
|
C36
|
B:5B41401
|
3.6
|
35.6
|
1.0
|
CD2
|
B:LEU1195
|
3.6
|
32.9
|
1.0
|
CE2
|
B:PHE1134
|
3.9
|
36.1
|
1.0
|
CD2
|
B:PHE1134
|
4.0
|
36.0
|
1.0
|
CG
|
B:LEU1195
|
4.1
|
31.5
|
1.0
|
C31
|
B:5B41401
|
4.1
|
34.3
|
1.0
|
O
|
B:VAL1220
|
4.2
|
23.6
|
1.0
|
CE2
|
B:PHE1200
|
4.4
|
38.1
|
1.0
|
CG1
|
B:VAL1220
|
4.5
|
24.1
|
1.0
|
CB
|
B:VAL1139
|
4.6
|
26.3
|
1.0
|
C
|
B:VAL1220
|
4.6
|
25.2
|
1.0
|
CG2
|
B:VAL1139
|
4.6
|
25.9
|
1.0
|
CD2
|
B:HIS1202
|
4.8
|
35.0
|
1.0
|
CA
|
B:ALA1221
|
4.8
|
28.4
|
1.0
|
N
|
B:ALA1221
|
4.9
|
26.4
|
1.0
|
CD2
|
B:PHE1200
|
4.9
|
37.7
|
1.0
|
CB
|
B:VAL1220
|
4.9
|
24.4
|
1.0
|
CZ
|
B:PHE1200
|
5.0
|
36.0
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 5 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1401
b:32.2
occ:1.00
|
F7
|
B:5B41401
|
0.0
|
32.2
|
1.0
|
C1
|
B:5B41401
|
1.3
|
31.4
|
1.0
|
C2
|
B:5B41401
|
2.4
|
31.3
|
1.0
|
C6
|
B:5B41401
|
2.4
|
30.5
|
1.0
|
O9
|
B:5B41401
|
2.7
|
31.3
|
1.0
|
CG1
|
B:VAL1092
|
3.3
|
41.2
|
1.0
|
CD1
|
B:LEU1157
|
3.6
|
36.5
|
1.0
|
C3
|
B:5B41401
|
3.6
|
30.4
|
1.0
|
C5
|
B:5B41401
|
3.6
|
30.8
|
1.0
|
CG2
|
B:VAL1092
|
3.6
|
40.8
|
1.0
|
CB
|
B:LYS1110
|
3.7
|
36.9
|
1.0
|
C10
|
B:5B41401
|
3.9
|
30.8
|
1.0
|
CE1
|
B:PHE1223
|
4.0
|
34.6
|
1.0
|
CD
|
B:LYS1110
|
4.1
|
38.8
|
1.0
|
CB
|
B:VAL1092
|
4.1
|
41.2
|
1.0
|
C4
|
B:5B41401
|
4.1
|
30.4
|
1.0
|
CG
|
B:LYS1110
|
4.3
|
37.0
|
1.0
|
CD1
|
B:PHE1223
|
4.3
|
34.8
|
1.0
|
C15
|
B:5B41401
|
4.4
|
29.6
|
1.0
|
CA
|
B:LYS1110
|
4.5
|
36.3
|
1.0
|
O24
|
B:5B41401
|
4.6
|
32.0
|
1.0
|
N
|
B:LYS1110
|
4.8
|
34.1
|
1.0
|
CB
|
B:ALA1108
|
4.8
|
34.6
|
1.0
|
N22
|
B:5B41401
|
4.8
|
32.3
|
1.0
|
CZ
|
B:PHE1223
|
4.9
|
34.3
|
1.0
|
C11
|
B:5B41401
|
5.0
|
30.4
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5dg5
Go back to
Fluorine Binding Sites List in 5dg5
Fluorine binding site 6 out
of 6 in the Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Crystal Structure of the Tyrosine Kinase Domain of the Hepatocyte Growth Factor Receptor C-Met in Complex with Altiratinib Analog Dp- 4157 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1401
b:30.9
occ:1.00
|
F8
|
B:5B41401
|
0.0
|
30.9
|
1.0
|
C4
|
B:5B41401
|
1.3
|
30.4
|
1.0
|
C3
|
B:5B41401
|
2.4
|
30.4
|
1.0
|
C5
|
B:5B41401
|
2.4
|
30.8
|
1.0
|
N22
|
B:5B41401
|
2.7
|
32.3
|
1.0
|
CB
|
B:ALA1221
|
3.2
|
29.4
|
1.0
|
CD2
|
B:LEU1140
|
3.3
|
30.3
|
1.0
|
CB
|
B:PHE1223
|
3.5
|
34.3
|
1.0
|
O27
|
B:5B41401
|
3.5
|
33.0
|
1.0
|
CA
|
B:PHE1223
|
3.6
|
33.8
|
1.0
|
C2
|
B:5B41401
|
3.6
|
31.3
|
1.0
|
C6
|
B:5B41401
|
3.7
|
30.5
|
1.0
|
N
|
B:PHE1223
|
3.7
|
35.7
|
1.0
|
CG
|
B:PHE1223
|
4.0
|
35.3
|
1.0
|
C23
|
B:5B41401
|
4.1
|
32.8
|
1.0
|
C1
|
B:5B41401
|
4.1
|
31.4
|
1.0
|
CD1
|
B:PHE1223
|
4.2
|
34.8
|
1.0
|
N
|
B:ASP1222
|
4.2
|
31.8
|
1.0
|
CG
|
B:MET1211
|
4.4
|
34.4
|
1.0
|
C
|
B:ASP1222
|
4.4
|
34.7
|
1.0
|
CA
|
B:ALA1221
|
4.4
|
28.4
|
1.0
|
SD
|
B:MET1211
|
4.4
|
36.7
|
1.0
|
C26
|
B:5B41401
|
4.5
|
33.5
|
1.0
|
C
|
B:ALA1221
|
4.7
|
29.4
|
1.0
|
CG
|
B:LEU1140
|
4.7
|
29.3
|
1.0
|
O9
|
B:5B41401
|
4.8
|
31.3
|
1.0
|
CD2
|
B:PHE1223
|
4.8
|
34.4
|
1.0
|
C25
|
B:5B41401
|
4.8
|
33.4
|
1.0
|
O
|
B:ASP1222
|
4.9
|
36.5
|
1.0
|
O24
|
B:5B41401
|
4.9
|
32.0
|
1.0
|
CA
|
B:ASP1222
|
5.0
|
34.6
|
1.0
|
|
Reference:
B.D.Smith,
M.D.Kaufman,
C.B.Leary,
B.A.Turner,
S.C.Wise,
Y.M.Ahn,
R.J.Booth,
T.M.Caldwell,
C.L.Ensinger,
M.M.Hood,
W.P.Lu,
T.W.Patt,
W.C.Patt,
T.J.Rutkoski,
T.Samarakoon,
H.Telikepalli,
L.Vogeti,
S.Vogeti,
K.M.Yates,
L.Chun,
L.J.Stewart,
M.Clare,
D.L.Flynn.
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance Via Balanced Inhibition of Met, TIE2, and VEGFR2. Mol.Cancer Ther. V. 14 2023 2015.
ISSN: ESSN 1538-8514
PubMed: 26285778
DOI: 10.1158/1535-7163.MCT-14-1105
Page generated: Thu Aug 1 08:44:54 2024
|